Search results
Beyond BCMA-Directed CAR T-Cell Therapy
MedPage Today· 5 days agoAlthough survival rates for patients with multiple myeloma are improving, with a 5-year rate of about 60%, many patients relapse after treatment....
New stem cell transplant procedure offers new hope for patients at Novant Health
WSOC-TV Charlotte· 20 hours agoA patient undergoing cancer treatment at Novant Health in Charlotte has new hope after learning of a...
Texas Wesleyan’s new basketball coach has cancer. ‘It will come back. I don’t know when’
Fort Worth Star-Telegram via Yahoo Sports· 6 days agoIt started in 2021, when he noticed pain in his lower back. Some days...salt baths, but that was a...
Living Drugs that Fight Cancer | Newswise
Newswise· 2 days agoAlthough the process collects patients’ own white blood cells, they must still undergo a mild chemotherapy to weaken their immune systems — known as...
Gateway - The Root
The Root· 7 days agoIn an exclusive interview with NBC News, Mutulu Shakur detailed life post-incarceration. Shakur, who is Tupac Shakur’s stepfather, was released on parole from federal prison on Dec. 16 after ...
These 2 ‘Strong Buy’ Penny Stocks Could Rally to $10 (or More), Say Analysts
TipRanks via Yahoo Finance· 5 days agoThe markets are on a solid upward trend this year, with the S&P 500’s year-to-date gain nearing 16%....
Groundbreaking cancer treatment may trigger more cancer – but here’s why you shouldn’t worry
The Conversation· 6 days agoIn the last few decades, scientists have finally learned to harness the immune system to successfully treat cancer. Car-T therapy, short for “chimeric antigen receptor T-cell”, is a cutting-edge ...
Beginning of the End: Upcoming Deadlines, Resolution Updates in Mass Tort Litigation | New York Law...
Law.com· 5 days agoThe Boy Scouts of America (BSA) bankruptcy has a pivotal deadline this summer, which marks a...
Rutherrin(R) Demonstrates Complete Response in Lung Cancer Preclinically
Digital Journal· 6 days agoTORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel...
Morningstar· 5 days agoALPHA3 Trial Has the Potential to Position Cema-cel as Part of First Line (1L) Treatment for LBCL to Improve Cure RatesFirst Prospective Trial to Incorporate the Foresight Diagnostics’s Investigational CLARITY™ Test to Identify Patients with LBCL Who
